mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
NCT07557602
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
EBV
Interventions
BIOLOGICAL:
VXCO-102
BIOLOGICAL:
Placebo
Sponsor
Vaccine Company, Inc.